DE69812962D1 - Oral anzuwendende Arzneizubereitung enthaltend S-(3-Hydroxypropyl)-L-Cystein - Google Patents

Oral anzuwendende Arzneizubereitung enthaltend S-(3-Hydroxypropyl)-L-Cystein

Info

Publication number
DE69812962D1
DE69812962D1 DE69812962T DE69812962T DE69812962D1 DE 69812962 D1 DE69812962 D1 DE 69812962D1 DE 69812962 T DE69812962 T DE 69812962T DE 69812962 T DE69812962 T DE 69812962T DE 69812962 D1 DE69812962 D1 DE 69812962D1
Authority
DE
Germany
Prior art keywords
cysteine
hydroxypropyl
pharmaceutical preparation
preparation containing
oral pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69812962T
Other languages
English (en)
Other versions
DE69812962T2 (de
Inventor
Misao Murata
Yukihiro Saito
Hideyoshi Kanbe
Shuji Yamauchi
Akira Iwasa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hisamitsu Pharmaceutical Co Inc
Original Assignee
SSP Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SSP Co Ltd filed Critical SSP Co Ltd
Application granted granted Critical
Publication of DE69812962D1 publication Critical patent/DE69812962D1/de
Publication of DE69812962T2 publication Critical patent/DE69812962T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/10—Expectorants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69812962T 1997-07-16 1998-10-20 Oral anzuwendende Arzneizubereitung enthaltend S-(3-Hydroxypropyl)-L-Cystein Expired - Lifetime DE69812962T2 (de)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
JP19110597A JP4098850B2 (ja) 1997-07-16 1997-07-16 Ｓ−（３−ヒドロキシプロピル）−ｌ−システインを含有する経口用製剤
CA002251297A CA2251297C (en) 1997-07-16 1998-10-19 Oral preparations comprising s-(3-hydroxypropyl)-l-cysteine
EP98119726A EP0998926B1 (de) 1997-07-16 1998-10-20 Oral anzuwendende Arzneizubereitung enthaltend S-(3-Hydroxypropyl)-L-Cystein
KR10-1998-0044204A KR100525128B1 (ko) 1997-07-16 1998-10-21 S-(3-히드록시프로필)-l-시스테인을 함유하는 경구 제제
US09/176,155 US6441040B1 (en) 1997-07-16 1998-10-21 Oral preparations comprising S-(3-hydroxypropyl)-L-cysteine
CNB981226477A CN1155373C (zh) 1997-07-16 1998-11-19 S-(3-羟丙基)-l-半胱氨酸口服制剂组合物

Publications (2)

Publication Number Publication Date
DE69812962D1 true DE69812962D1 (de) 2003-05-08
DE69812962T2 DE69812962T2 (de) 2003-12-18

Family

ID=31999786

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69812962T Expired - Lifetime DE69812962T2 (de) 1997-07-16 1998-10-20 Oral anzuwendende Arzneizubereitung enthaltend S-(3-Hydroxypropyl)-L-Cystein

Country Status (8)

Country Link
US (1) US6441040B1 (de)
EP (1) EP0998926B1 (de)
JP (1) JP4098850B2 (de)
KR (1) KR100525128B1 (de)
CN (1) CN1155373C (de)
CA (1) CA2251297C (de)
DE (1) DE69812962T2 (de)
ES (1) ES2191241T3 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1391201A4 (de) * 2001-05-25 2004-06-30 Ssp Co Ltd Medizinische zusammensetzungen
JP3805646B2 (ja) 2001-05-25 2006-08-02 久光メディカル株式会社 医薬液剤
EP1391200A4 (de) * 2001-05-25 2004-06-16 Ssp Co Ltd Arzneimittel
JP2005298338A (ja) * 2002-02-27 2005-10-27 Eisai Co Ltd 速崩壊性圧縮成形製剤
JP4490668B2 (ja) * 2003-10-23 2010-06-30 田辺三菱製薬株式会社 下痢治療薬
CN100404026C (zh) * 2005-09-23 2008-07-23 北京德众万全药物技术开发有限公司 一种含福多司坦的口服药物组合物
CN102501157A (zh) * 2011-11-21 2012-06-20 长春大学 调压式砂带研磨装置
CN103768011A (zh) * 2012-10-23 2014-05-07 天津药物研究院 福多司坦注射剂及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2187326B1 (de) * 1972-06-15 1975-10-17 Rech Pharm Scientifiques
NL8502092A (nl) * 1985-07-22 1987-02-16 Cedona Haarlemmer Pharma Tabletten die s-carboxymethylcysteine bevatten en werkwijze voor de bereiding daarvan.
JPH0788352B2 (ja) * 1988-06-16 1995-09-27 エスエス製薬株式会社 ヒドロキシアルキルシステイン誘導体およびこれを含有する去痰剤
KR100304064B1 (ko) * 1993-08-12 2001-11-22 다카하시 미치나오 구강용조성물
US5614197A (en) * 1995-02-13 1997-03-25 Industrial Farmaceutica Cantabria, S.A. Polypodium extract as photoprotectant
EP0799616A1 (de) * 1996-04-01 1997-10-08 Takeda Chemical Industries, Ltd. Orale Zubereitung enthaltend ein Fumagillolderivat

Also Published As

Publication number Publication date
JPH1135459A (ja) 1999-02-09
JP4098850B2 (ja) 2008-06-11
DE69812962T2 (de) 2003-12-18
CA2251297C (en) 2007-05-29
CN1155373C (zh) 2004-06-30
EP0998926A1 (de) 2000-05-10
ES2191241T3 (es) 2003-09-01
KR100525128B1 (ko) 2005-12-28
EP0998926B1 (de) 2003-04-02
KR20000026603A (ko) 2000-05-15
CN1254558A (zh) 2000-05-31
US6441040B1 (en) 2002-08-27
CA2251297A1 (en) 2000-04-19

Similar Documents

Publication Publication Date Title
ATE265850T1 (de) Ibuprofenhaltige arzneizubereitung
EE200000395A (et) Peroraalne farmatseutiline pulseeriva vabanemisega annusvorm
ATE206924T1 (de) Oral anzuwendende arzneizubereitung enthaltend olanzapin
EE200000383A (et) Peroraalne farmatseutiline pikendatud vabanemisega annusvorm
DK0936913T4 (da) Oralt farmaceutisk præparat indeholdende ibandronat
DK0754061T3 (da) Ny oral farmaceutisk doseringsform
AU7375598A (en) Stable oral pharmaceutical dosage forms
DE69924999D1 (de) Lipasehemmer enthaltende pharmazeutische zusammensetzungen
ID24654A (id) Formulasi farmasi omeprazola
DE69822172D1 (de) Levosimendanhaltige oral anzuwendende arzneizusammensetzungen
ITMI982222A0 (it) Composizioni farmaceutiche orali contenenti buprenorfina
DE69713171D1 (de) Mundpflegezubereitung
PT868911E (pt) Formulacoes de rapamicina para administracao oral
DE59801987D1 (de) Pharmazeutische zusammensetzung enthaltend peptichemio
DE69830154D1 (de) Pharmazeutische zusammensetzungen
DE69812962D1 (de) Oral anzuwendende Arzneizubereitung enthaltend S-(3-Hydroxypropyl)-L-Cystein
NO20003284L (no) Farmasøytisk preparat for oral administrering
SE9402433D0 (sv) New oral pharmaceutical dosage form
SI1043976T1 (sl) Oralna farmacevtska dozirna oblika s podaljsanim sproscanjem
GB9711046D0 (en) Oral pharmaceutical compositions
SE9402925D0 (sv) Novel oral pharmaceutical composition
FI3862U1 (fi) Geelimuotoinen farmaseuttinen valmiste

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: BIOMEDIX CO.,LTD., TOKIO/TOKYO, JP

8327 Change in the person/name/address of the patent owner

Owner name: HISAMITSU MEDICAL CO., LTD., TOKIO/TOKYO, JP

8327 Change in the person/name/address of the patent owner

Owner name: HISAMITSU PHARMACEUTICAL CO., INC., TOSU, SAGA, JP